India plans periodic inspections of all clinical-trial sites

05/5/2013 | Business Standard (India)

India's Drug Controller General office announced plans to inspect all of the nation's clinical-trial sites at least annually to verify regulatory compliance. The inspections will cover Schedule Y drugs and cosmetics, good clinical practice and other regulatory requirements. The move follows criticism of the agency's failure to monitor human clinical trials more closely and is part of several other recent measures, including establishing an ethics committee and setting guidelines for compensation to those injured in clinical trials.

View Full Article in:

Business Standard (India)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Director of Clinical Research
Regenesis Biomedical, Inc.
Scottsdale, AZ
Actuary
Meridian Health Plan
Detroit, MI
Assistant Vice President - Dental Director
MetLife
Bridgewater, NJ